Research Article

NOL12 as an Oncogenic Biomarker Promotes Hepatocellular Carcinoma Growth and Metastasis

Figure 1

NOL12 is upregulated in HCC, and its expression is associated with poor survival in HCC patients. (a) Differential and (b) paired differential analysis of NOL12 in normal liver tissue and HCC tissue (). (c) Kaplan-Meier curve was used to analyze the overall survival (OS) rate of patients with high and low expression of NOL12 (). The correlation of NOL12 expression with clinicopathological characteristics: (d) race; (e) gender; (f) age; (g) grade; (h) metastasis status; (i) stage. .